Eicosapentaenoic acid as a modulator of inflammation
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (5), 779-785
- https://doi.org/10.1016/0006-2952(86)90246-7
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acidBiochemical and Biophysical Research Communications, 1983
- Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjectsAtherosclerosis, 1983
- Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZB x NZW F1 mice.JCI Insight, 1981
- Leukotriene B: a potential mediator of inflammationJournal of Pharmacy and Pharmacology, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980
- Transformations of 5,8,11,14,17-eicosapentaenoic acid in human plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS?The Lancet, 1978
- Role of prostaglandin-mediated vasodilatation in inflammationNature, 1977
- Diet-induced changes in plasma membrane fatty acid composition affect physical properties detected with a spin-label probeBiochemistry, 1977
- Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentineThe Journal of Pathology, 1971